Dergiler / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 8

Relationship between red cell distribution width and long-term mortality in patients with non-ST elevation acute coronary syndrome

Sayfa
634–639
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: A high RDW level on admission is associated with increased long-term mortality in patients with NST-ACS.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Red cell distribution width (RDW) has been reported to be a predictor of cardiac events in coronary artery disease (CAD).
📊
Temel Bulgular & Veri:Methods: In total, 202 patients with NST-ACS (159 males and 43 females) were retrospectively analyzed.
💡
Sonuç & Katkı:Conclusion: A high RDW level on admission is associated with increased long-term mortality in patients with NST-ACS.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Red cell distribution width (RDW) has been reported to be a predictor of cardiac events in coronary artery disease (CAD). Here, we hypothesized that RDW level on admission would be predictive of adverse outcomes in non-ST elevation acute coronary syndrome (NST-ACS). Methods: In total, 202 patients with NST-ACS (159 males and 43 females) were retrospectively analyzed. The patients were divided into two groups based on the 50th percentile of admission RDW levels. A high RDW group (n=100) was defined as those patients having RDW levels of >14.0. The relationship between RDW and primary endpoint (cardiovascular death), secondary endpoints [(reinfarction, repeat target vessel revascularization-percutaneous/surgical)], and major adverse cardiac events (MACE) were assessed. The median follow-up time was 18 (13-24) months. Results: The patients in the high RDW group were older (62.9 vs. 57.5, p=0.001). Multivessel disease, low-density lipoprotein, creatinine, platelet, CK-MB, troponin I, and RDW were higher (p=0.047, p=0.003, p=0.012, p=0.012, p=0.017, p<0.001, respectively), and gender (male/female), ejection fraction, and hemoglobin levels were lower (p=0.021, p=0.04, p=0.016, respectively) in the high RDW group. Cardiovascular death and MACE were higher in the high RDW group (16% vs. 4.9%, p=0.01, 52% vs. 31.4%, p=0.003, respectively). By multiple regression analysis in 202 patients, age &#8805;65 and RDW >14.0% on admission were found to be powerful independent predictors of cardiovascular mortality (OR: 4.5, 95% CI: 1.5-13.1, p=0.005, OR: 3.0, 95% CI: 1.0-8.9, p=0.039, respectively). Conclusion: A high RDW level on admission is associated with increased long-term mortality in patients with NST-ACS.

🔖

Bu Makaleye Atıf Yap

BEKLER, A., TENEKECİOĞLU, E., ERBAĞ, G., TEMİZ, A., ALTUN, B., BARUTÇU, A., GAZİ, E., GÜNEŞ, F., YILMAZ, M. (2015). Relationship between red cell distribution width and long-term mortality in patients with non-ST elevation acute coronary syndrome. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 8, 634–639. https://ajindex.com/articles/365946

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008
  2. [CrossRef] 2. Van Kimmenade RR, Mohammed AA, Uthamalingam S, Van der Meer P, Felker GM, Januzzi JL Jr. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010
  3. [CrossRef] 3. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 2009
  4. [CrossRef] 4. Uyarel H, Ergelen M, Çicek G, Kaya MG, Ayhan E, Türkkan C, et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 2011
  5. [CrossRef] 5. Weiss G, Goodnough LT. Anemia of chronic disease. New Engl J Med 2005
  6. [CrossRef] 6. Kato H, Ishida J, Imagawa S, Saito T, Suzuki N, Matsuoka T, et al. Enhanced erythropoiesis mediated by activation of the renin angiotensin system via angiotensin II type 1a receptor. FASEB J 2005
  7. Cole J, Ertoy D, Lin H, Sutliff RL, Ezan E, Guyene TT, et al. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 2000
  8. [CrossRef] 8. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009
  9. Thygesen K, Alpert J S, White HD, Jaffe AS, Apple FS, Galvani M, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Circulation 2007
  10. [CrossRef] 10. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 2014
  11. [CrossRef] 11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011
  12. [CrossRef] 12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006
  13. [CrossRef] 13. Gensini GG. A more meaningful scoring sys